Nabiximols (Sativex), a multiple sclerosis drug made from a combination of TCH and CBD, is approved in the United Kingdom and Canada to treat MS pain. However, researchers think the CBD in the drug may be contributing more with its anti-inflammatory properties than by acting against the pain. Clinical trials of CBD are necessary to determine whether or not it should be used for pain management.
Nora Volkow from the National Institute on Drug Abuse reiterated the decision of (then) two dozen states to allow medical marijuana to be used in one way or another in their jurisdictions. This should open everyone’s eyes to the sanctioning of a non-addictive, non-psychoactive substance which has been linked to benefits for patients suffering from seizure disorders, quite a few neurodegenerative disorders or pain resulting from cancer.
The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product.
The cannabis plant contains a unique group of carbon compounds often referred to a phytocannabinoids. The most common ingredient is THC, which creates the euphoric high effect. Due to the THC element in the plant, marijuana is often associated with a stoner stigma of people only wanting to get high. But that is far from the truth. Cannabis also contains other medicinal compounds including cannabinol, cannabigerol, cannabidiol, and cannabichromene.